170 related articles for article (PubMed ID: 35676658)
1. Prognostic role of an inflammation scoring system in radical resection of oral squamous cell carcinoma.
Wu M; Ye P; Zhang W; Zhu H; Yu H
BMC Oral Health; 2022 Jun; 22(1):226. PubMed ID: 35676658
[TBL] [Abstract][Full Text] [Related]
2. Combined fibrinogen and neutrophil-lymphocyte ratio as a prognostic marker of advanced esophageal squamous cell carcinoma.
Kijima T; Arigami T; Uchikado Y; Uenosono Y; Kita Y; Owaki T; Mori S; Kurahara H; Kijima Y; Okumura H; Maemura K; Ishigami S; Natsugoe S
Cancer Sci; 2017 Feb; 108(2):193-199. PubMed ID: 27889946
[TBL] [Abstract][Full Text] [Related]
3. Combination of preoperative fibrinogen and neutrophil to lymphocyte ratio is a predictive prognostic factor in ESCC and AEG systematic review.
Tianxing G; Xiaojie P; Lihuan Z; Yangyun H
Biosci Rep; 2019 Oct; 39(10):. PubMed ID: 31511434
[TBL] [Abstract][Full Text] [Related]
4. Fibrinogen and Neutrophil-to-lymphocyte Ratio Predicts Survival in Patients with Advanced Hypopharyngeal Squamous Cell Carcinoma.
Kuwahara T; Takahashi H; Sano D; Matsuoka M; Hyakusoku H; Hatano T; Hiiragi Y; Oridate N
Anticancer Res; 2018 Sep; 38(9):5321-5330. PubMed ID: 30194184
[TBL] [Abstract][Full Text] [Related]
5. Systemic inflammatory response in predicting outcomes of patients undergoing curative resection for oral squamous cell carcinoma.
Zubair F; McMahon J; Kryklyas G; Wicks C
Br J Oral Maxillofac Surg; 2022 Jun; 60(5):589-595. PubMed ID: 35248409
[TBL] [Abstract][Full Text] [Related]
6. The Prognostic Role of a Combined Fibrinogen and Neutrophil-to-Lymphocyte Ratio Score in Patients with Resectable Hepatocellular Carcinoma: A Retrospective Study.
Kong W; Xu H; Cheng J; Fang Z; Wang H; Zhang J; Wang X; Dai T; Gao Y
Med Sci Monit; 2020 Jan; 26():e918824. PubMed ID: 31929496
[TBL] [Abstract][Full Text] [Related]
7. A novel prognostic score based on systemic inflammatory biomarkers for patients with oral squamous cell carcinoma.
Zhuang Z; Li Y; Hong Y; Chen L; Qian J; Lin J; Chen Q; Qiu Y; Lin L; Shi B; Pan L; Zheng X; Wang J; Liu F; He B; Chen F
Oral Dis; 2022 Apr; 28(3):631-638. PubMed ID: 33426698
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the Fibrinogen and Neutrophil-Lymphocyte Ratio in Esophageal Squamous Cell Carcinoma: A Promising Blood Marker of Tumor Progression and Prognosis.
Arigami T; Okumura H; Matsumoto M; Uchikado Y; Uenosono Y; Kita Y; Owaki T; Mori S; Kurahara H; Kijima Y; Ishigami S; Natsugoe S
Medicine (Baltimore); 2015 Oct; 94(42):e1702. PubMed ID: 26496280
[TBL] [Abstract][Full Text] [Related]
9. High fibrinogen-albumin ratio index (FARI) predicts poor survival in head and neck squamous cell carcinoma patients treated with surgical resection.
Wang S; Feng Y; Xie Y; Zhao X; Ma J; Liu X; Hu C; Hou T
Eur Arch Otorhinolaryngol; 2022 Sep; 279(9):4541-4548. PubMed ID: 35462579
[TBL] [Abstract][Full Text] [Related]
10. The combination of plasma fibrinogen and neutrophil lymphocyte ratio (F-NLR) is a predictive factor in patients with resectable non small cell lung cancer.
Wang H; Zhao J; Zhang M; Han L; Wang M; Xingde L
J Cell Physiol; 2018 May; 233(5):4216-4224. PubMed ID: 29057536
[TBL] [Abstract][Full Text] [Related]
11. Prognostic implications of preoperative systemic inflammatory markers in oral squamous cell carcinoma, and correlations with the local immune tumor microenvironment.
Ruiz-Ranz M; Lequerica-Fernández P; Rodríguez-Santamarta T; Suárez-Sánchez FJ; López-Pintor RM; García-Pedrero JM; de Vicente JC
Front Immunol; 2022; 13():941351. PubMed ID: 35958590
[TBL] [Abstract][Full Text] [Related]
12. Prognostic analysis of the plasma fibrinogen combined with neutrophil-to-lymphocyte ratio in patients with non-small cell lung cancer after radical resection.
Wang GX; Huang ZN; Ye YQ; Tao SM; Xu MQ; Zhang M; Xie MR
Thorac Cancer; 2023 May; 14(15):1383-1391. PubMed ID: 37037492
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of the Combined Index of Plasma Fibrinogen and the Neutrophil-Lymphocyte Ratio in Gastric Cancer.
Yamamoto M; Kurokawa Y; Kobayashi N; Takahashi T; Miyazaki Y; Tanaka K; Makino T; Yamasaki M; Nakajima K; Mori M; Doki Y
World J Surg; 2020 Jan; 44(1):207-212. PubMed ID: 31559484
[TBL] [Abstract][Full Text] [Related]
14. A Cumulative Score Based on Preoperative Neutrophil-Lymphocyte Ratio and Fibrinogen in Predicting Overall Survival of Patients with Glioblastoma Multiforme.
Hao Y; Li X; Chen H; Huo H; Liu Z; Tian F; Chai E
World Neurosurg; 2019 Aug; 128():e427-e433. PubMed ID: 31042598
[TBL] [Abstract][Full Text] [Related]
15. Preoperative Neutrophil-to-Lymphocyte Ratio Predicts the Prognosis of Oral Squamous Cell Carcinoma: A Large-Sample Prospective Study.
Chen F; Lin L; Yan L; Qiu Y; Cai L; He B
J Oral Maxillofac Surg; 2017 Jun; 75(6):1275-1282. PubMed ID: 28011326
[TBL] [Abstract][Full Text] [Related]
16. A preoperative prognostic nutritional index is a prognostic indicator in oral squamous cell carcinoma patients undergoing radical surgery.
Watabe Y; Aoki K; Ichikawa H; Matsuzaki H; Ito A; Tanaka JI; Kamiyama I; Shigematsu S
Int J Oral Maxillofac Surg; 2021 Nov; 50(11):1413-1421. PubMed ID: 33663900
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis of the prognostic value of the neutrophil-to-lymphocyte ratio in oral squamous cell carcinoma.
Wang Y; Wang P; Andrukhov O; Wang T; Song S; Yan C; Zhang F
J Oral Pathol Med; 2018 Apr; 47(4):353-358. PubMed ID: 29406591
[TBL] [Abstract][Full Text] [Related]
18. [CD103
Li BW; Ren SQ; Chen SL; Lan TJ; Wu F; Li JS
Zhonghua Kou Qiang Yi Xue Za Zhi; 2023 Dec; 58(12):1257-1264. PubMed ID: 38061868
[No Abstract] [Full Text] [Related]
19. Prognostic Impact of Using Combined Plasma Fibrinogen Level and Neutrophil-to-Lymphocyte Ratio in Resectable Non-small Cell Lung Cancer.
Iwasaki M; Ishihara S; Okada S; Shimegi R; Shimomura M; Inoue M
Ann Surg Oncol; 2022 Sep; 29(9):5699-5707. PubMed ID: 35653068
[TBL] [Abstract][Full Text] [Related]
20. Correlation of Inflammatory Markers, Survival, and COX2 Expression in Oral Cancer and Implications for Prognosis.
Sano Y; Kogashiwa Y; Araki R; Enoki Y; Ikeda T; Yoda T; Nakahira M; Sugasawa M
Otolaryngol Head Neck Surg; 2018 Apr; 158(4):667-676. PubMed ID: 29359615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
